MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 52 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395 | -63.9% | 3,040 | 0.0% | 0.00% | – |
| Q2 2023 | $1,094 | -23.4% | 3,040 | 0.0% | 0.00% | – |
| Q1 2023 | $1,429 | -6.0% | 3,040 | 0.0% | 0.00% | – |
| Q4 2022 | $1,520 | -24.0% | 3,040 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 3,040 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 3,040 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 3,040 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -25.0% | 3,040 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | +100.0% | 3,040 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -100.0% | 3,040 | -50.0% | 0.00% | – |
| Q1 2021 | $6,384,000 | +159500.0% | 6,080 | +100.0% | 0.00% | – |
| Q4 2020 | $4,000 | +100.0% | 3,040 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 3,040 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 3,040 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 3,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,207,337 | $2,903,000 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 331,846 | $211,000 | 0.46% |
| Arkadios Wealth Advisors | 1,399,000 | $890,000 | 0.14% |
| Kingsbury Capital Investment Advisors LLC | 119,949 | $76,000 | 0.12% |
| NEVILLE RODIE & SHAW INC | 1,753,500 | $1,115,000 | 0.11% |
| JTC Employer Solutions Trustee Ltd | 775,000 | $508,000 | 0.08% |
| Platform Technology Partners | 162,410 | $103,000 | 0.06% |
| Main Street Financial Solutions, LLC | 400,826 | $255,000 | 0.04% |
| National Wealth Management Group, LLC | 46,000 | $29,256 | 0.04% |
| STALEY CAPITAL ADVISERS INC | 1,200,000 | $764,000 | 0.02% |